Revium Rx
RVRC
$0.50
$0.098924.66%
| 09/30/2010 | 06/30/2010 | 03/31/2010 | 09/30/2009 | ||
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | -- | -- | -- | |
| Cost of Revenue | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | |
| SG&A Expenses | 182.00K | 70.50K | 4.40K | 3.60K | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 182.00K | 70.50K | 4.40K | 3.60K | |
| Operating Income | -182.00K | -70.50K | -4.40K | -3.60K | |
| Income Before Tax | -182.00K | -70.50K | -4.40K | -3.60K | |
| Income Tax Expenses | -- | -- | -- | -- | |
| Earnings from Continuing Operations | -182.00K | -70.50K | -4.40K | -3.60K | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -182.00K | -70.50K | -4.40K | -3.60K | |
| EBIT | -182.00K | -70.50K | -4.40K | -3.60K | |
| EBITDA | -- | -- | -- | -- | |
| EPS Basic | -2.62 | -1.04 | -0.06 | -0.08 | |
| Normalized Basic EPS | -1.64 | -0.65 | -0.04 | -0.05 | |
| EPS Diluted | -2.62 | -1.04 | -0.06 | -0.08 | |
| Normalized Diluted EPS | -1.64 | -0.65 | -0.04 | -0.05 | |
| Average Basic Shares Outstanding | 69.40K | 67.70K | 69.90K | 47.40K | |
| Average Diluted Shares Outstanding | 69.40K | 67.70K | 69.90K | 47.40K | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |
